# Pharmacogenomics-and-ML-identify-KRAS-G12D-MEK-inhibitors-in-colorectal-cancer
Integrative Pharmacogenomics and Supervised Machine Learning Identify Drug Sensitivity Determinants and Candidate Inhibitors Targeting KRASG12Dâ€“MEK Signaling in Colorectal Cancer.
